LOS ANGELES — Ophthalmologists should act early to prevent a “vicious” cycle of neuropathy and inflammation in corneal disease, according to a speaker at the American Society of Cataract and Refractive Surgery meeting.In this year’s Richard L. Lindstro…
Author: Healio ophthalmology
Manual or femtosecond laser channel dissection: Which is better for CAIRS implantation?
Click here to read the Cover Story, “Experts explore CAIRS through landmarks that shaped its evolution.”We did not have a femtosecond laser in our practice, so we started implanting CAIRS manually, and it has been so successful that we have not been mo…
Experts explore CAIRS through landmarks that shaped its evolution
Corneal allogenic intrastromal ring segments, or CAIRS, have been gaining momentum over the years as a minimally invasive procedure for treating keratoconus and corneal ectasia.“CAIRS is a type of mid-peripheral, mid-stromal additive lamellar keratopla…
Academic medical researchers face the reality of federal cuts
President Donald J. Trump’s administration has announced major federal cuts in the name of efficiency, but this has massive repercussions for academic medical researchers and the patients who rely on their work, according to experts.The NIH has cancele…
VIDEO: Subcutaneous injection shows promise for wet AMD, DME
FORT LAUDERDALE, Fla. — In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for migaldendranib for the treatment of wet age-related macular degeneration and diabetic macular edema.The subcutaneous injection is a tyrosin…
Do all cases of acute optic neuritis require high-dose corticosteroids?
SEVILLE, Spain — Treatment of optic neuritis with corticosteroids, findings from the Optic Neuritis Treatment Trial and the validity of previous treatment paradigms were debated at the Congress on Controversies in Ophthalmology.Do all patients with acu…
Cataract surgery fear greater among patients with better vision
Fear of cataract surgery is greater among patients with better vision and is not influenced by knowledge of cataracts or overall health literacy, according to a study published in Clinical Ophthalmology.The study was inspired by the attitudes of patien…
VIDEO: Surgeons satisfied with 27-gauge vitrector for pars plana anterior vitrectomy
LOS ANGELES — In this Healio Video Perspective from the ASCRS meeting, Brandon D. Ayres, MD, discusses the effectiveness and safety of a 27-gauge needle-tipped vitrector for pars plana anterior vitrectomy.In 27 cases, vitreous was “adequately cleared” …
Ophthalmic exoscope with augmented-reality headset may improve ergonomics
FORT LAUDERDALE, Fla. — Using an ophthalmic exoscope with an augmented reality headset instead of a standard operating microscope may yield ergonomic benefits for ophthalmologists, according to a speaker here.Baruch D. Kuppermann, MD, PhD, who presente…
VIDEO: Intraoperative OCT increases precision of subretinal gene therapy delivery
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Lejla Vajzovic, MD, FASRS, shares pearls on delivery of subretinal gene therapy to treat common and inherited retinal diseases.Vajzovic overviewed tips and tricks …
Artificial tears, other eye care products recalled after manufacturing ‘deviations’
Editor’s note: This is a developing news story. Please check back soon for updates.An artificial tear solution is one of five ophthalmic products now under recall due to lapses in manufacturing processes, according to the FDA.The voluntary recalls were…
Aflibercept 8 mg shows sustained improvements in wet AMD through 156 weeks
FORT LAUDERDALE, Fla. — Aflibercept 8 mg demonstrated sustained functional and anatomic improvements in patients with wet age-related macular degeneration through 156 weeks, according to a presenter.At the Retina World Congress, David T. Wong, MD, FRCS…
VIDEO: Macular hole repair technique uses decellularized human amniotic membrane
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Deepika Malik, MD, discusses a technique for macular hole repair that uses a decellularized human amniotic membrane.“Use this decellularized basement membrane in p…
Q&A: Clinical Trials at the Summit explores new data in vitreoretinal diseases
Clinical Trials at the Summit will be held Saturday, June 21, at Fontainebleau Las Vegas.The meeting will focus on the latest data in vitreoretinal care from ongoing clinical trials. Through an emphasis on relationship building, the meeting will explor…
VIDEO: Myopia progression ‘comes to a crawl’ around age 13 in diverse cohort
SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, Patrick Johnson, PhD, president of Sydnexis, shares data on myopia progression that is representative of children in the U.S.“In a representative population of the U.S. — not an e…
VIDEO: Dexamethasone implant shows positive results in DME after anti-VEGF treatment
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Baruch D. Kuppermann, MD, PhD, shares positive data on the dexamethasone intravitreal implant for diabetic macular edema.The retrospective analysis included 167 pa…
VIDEO: Elamipretide for dry AMD targets mitochondria, protects photoreceptors
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Reenie McCarthy, CEO of Stealth BioTherapeutics, discusses elamipretide for the treatment of dry age-related macular degeneration.According to McCarthy, elamipreti…
Consider complications when treating pediatric uveitis with surgery
FORT LAUDERDALE, Fla. — In some cases of pediatric pars planitis, surgical intervention may be necessary, but possible complications must be considered, according to a speaker.At the Retina World Congress, Lisa J. Faia, MD, discussed a case in which a …
VIDEO: Neurotech prepares to launch Encelto for macular telangiectasia type 2
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Richard Small, CEO of Neurotech Pharmaceuticals, provides an update on Encelto for macular telangiectasia type 2.Ahead of the encapsulated cell therapy’s June laun…
Veligrotug receives breakthrough therapy designation for thyroid eye disease
Editor’s note: This is a developing news story. Please check back soon for updates.Viridian Therapeutics received breakthrough therapy designation from the FDA for veligrotug for the treatment of thyroid eye disease, according to a press release.Veligr…